San Jose, California—September 20, 2012—Maxim Integrated Products (NASDAQ: MXIM) announced the launch of a new vital sign monitoring shirt that enables more effective preventive medical care by allowing healthcare professionals to perform long-term medical monitoring at a cost-effective rate. This highly integrated shirt can measure 3-lead ECG, body temperature, and motion. It integrates all diagnostic tools into a conveniently wearable shirt.

This shirt design, called “Fit,” integrates dry ECG sensor technology, complex signal processing technology, temperature sensors, motion sensors, ultra-low power microcontrollers, and wireless devices. This shirt design is the result of a collaboration combining the accumulated experience, expertise, and creativity of three companies: Maxim Integrated, Clearbridge VitalSigns, and Orbital Research. This shirt design opens a new chapter in preventive medical care, enabling savings of up to 10 times in medical treatment costs.

Maxim's contribution:
• The ultra-low power MAXQ622 microcontroller is easy to use and allows for convenient programming of multi-technology interfacing.
• The MAX8671 power management IC provides a quiet power supply and can efficiently switch multiple sensors.
• The MAX6656 ultra-low power temperature sensor can be plug-and-play integrated into a system.
• The MAX3204 USB protection device enables safe protection of system components from shock and ESD risks.

Contributions by Clearbridge VitalSigns:
• The ultra-low power multi-channel CVBS1202 ECG system-on-chip can capture 3-lead ECG data for an extended period.
• Clearbridge VitalSigns' advanced motion artifact removal algorithms can effectively separate ECG signals from noise. This addresses the mechanical challenges required to ensure comfortable shirt wear for users of almost any body type, enabling proper electrode placement and superior signal quality.
• Adopts Clearbridge VitalSigns' innovative 3-lead ultra-thin CardioLeaf® housing design
• Provides a fully integrated GUI application available for desktop and mobile devices

Contributions by Orbital Research:
• Dry electrodes, a patented and FDA-approved technology, can capture all minute features of ECG waveforms without causing discomfort to the shirt wearer. Dry electrodes do not require preparation work or adhesives for skin attachment and can continuously read clinical-grade ECG signals for extended periods while the wearer wears a shirt.

Industry evaluation
“By 2016, the wearable device market is projected to reach an annual volume of over 100 million units. These devices will enable the capture of finer features during tracking, monitoring, and treatment, and in most cases, will allow for connectivity via mobile phones.” ABI Research, August 17, 2011, www.abiresearch.com/press/wearable-wireless-medical-devices-to-top-100-milli
• “Maxim is joining forces with companies such as C-Learbridge VitalSigns and Orbital Research to develop new integrated solutions that can take healthcare delivery to the next level.” – Chris Neil, Senior Vice President, Maxim
• “Clearbridge VitalSigns is sparing no effort to develop next-generation biosignal medical devices that are extremely thin, extremely light, extremely convenient, and long-lasting, utilizing a unique, integrated biomedical chip design. We are pleased to collaborate with Maxim to develop this shirt.” – Johnson Chen, Executive Director, Clearbridge VitalSigns

Click here to view the image.